Summit Financial LLC Acquires 1,201 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Summit Financial LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,729 shares of the healthcare conglomerate’s stock after buying an additional 1,201 shares during the period. Summit Financial LLC’s holdings in UnitedHealth Group were worth $12,509,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter worth $25,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at $30,000. Promus Capital LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth about $32,000. Pillar Financial Advisors LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $40,000. Finally, Legacy Investment Solutions LLC purchased a new stake in shares of UnitedHealth Group in the 3rd quarter worth approximately $57,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Price Performance

NYSE:UNH opened at $515.47 on Monday. The firm has a market cap of $471.51 billion, a price-to-earnings ratio of 33.26, a PEG ratio of 1.37 and a beta of 0.62. The firm’s fifty day moving average is $508.81 and its two-hundred day moving average is $543.92. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the business earned $5.83 earnings per share. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.63%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. Barclays lowered their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Wells Fargo & Company dropped their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. KeyCorp reissued an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.